IRIS
MAURIZI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.145
EU - Europa 1.211
AS - Asia 976
SA - Sud America 172
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 21
Totale 4.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.086
SG - Singapore 439
RU - Federazione Russa 356
IT - Italia 241
CN - Cina 201
IE - Irlanda 194
BR - Brasile 150
DE - Germania 112
VN - Vietnam 105
HK - Hong Kong 94
SE - Svezia 72
GB - Regno Unito 61
TR - Turchia 42
UA - Ucraina 35
CA - Canada 33
FR - Francia 30
FI - Finlandia 29
IN - India 26
PL - Polonia 14
JP - Giappone 13
NL - Olanda 13
ES - Italia 12
BE - Belgio 10
IQ - Iraq 10
MX - Messico 10
LT - Lituania 9
CZ - Repubblica Ceca 8
ZA - Sudafrica 7
AR - Argentina 6
AE - Emirati Arabi Uniti 5
BD - Bangladesh 5
PK - Pakistan 5
VE - Venezuela 5
EC - Ecuador 4
ID - Indonesia 4
RO - Romania 4
AT - Austria 3
AZ - Azerbaigian 3
CL - Cile 3
EU - Europa 3
HN - Honduras 3
PH - Filippine 3
TN - Tunisia 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
NP - Nepal 2
RS - Serbia 2
UZ - Uzbekistan 2
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LC - Santa Lucia 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.528
Salva come PNG Salva come JPEG
Città #
Dallas 305
Singapore 253
Chandler 221
San Jose 215
Dublin 192
Ashburn 161
Jacksonville 107
Santa Clara 107
The Dalles 94
Hong Kong 93
Council Bluffs 82
Boardman 77
New York 74
L’Aquila 46
Beijing 43
Moscow 38
Ann Arbor 33
Ho Chi Minh City 32
Rome 30
Lawrence 28
Princeton 28
Los Angeles 27
L'aquila 25
Falkenstein 24
Hanoi 24
Wilmington 24
Izmir 23
Kitzingen 21
Milan 20
Nanjing 20
Columbus 16
Munich 16
Lauterbourg 15
Dong Ket 14
Warsaw 14
Chennai 13
Montreal 13
Tokyo 13
Orem 12
San Mateo 12
Falls Church 11
Toronto 11
London 10
Nanchang 10
San Francisco 10
Shanghai 10
Stockholm 10
Brussels 9
Chicago 9
Helsinki 9
Kunming 9
Lappeenranta 9
Phoenix 9
São Paulo 9
Woodbridge 9
Brno 8
Seattle 8
Boston 7
Bremen 7
Denver 7
Johannesburg 7
Mexico City 7
Amsterdam 6
Aquila 6
Atlanta 6
Belo Horizonte 6
Biên Hòa 6
Dearborn 6
Norwalk 6
Poplar 6
West Jordan 6
Ankara 5
Brooklyn 5
Pescara 5
Teramo 5
Tianjin 5
Cologne 4
Curitiba 4
Da Nang 4
Frankfurt am Main 4
Fremont 4
Giugliano in Campania 4
Hebei 4
Houston 4
Jiaxing 4
Manchester 4
Mountain View 4
Secaucus 4
Thái Nguyên 4
Turku 4
Verona 4
Washington 4
Birmingham 3
City of London 3
Des Moines 3
Genoa 3
Hefei 3
Jakarta 3
Jinan 3
Madrid 3
Totale 2.967
Salva come PNG Salva come JPEG
Nome #
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE) 192
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 184
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 165
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 153
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 151
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 146
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 143
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 141
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 137
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy 133
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 129
Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications 129
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 128
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 126
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 124
The Great Beauty of the osteoclast 121
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 121
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women 120
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 119
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 115
Role of Neural (N)-Cadherin in Breast Cancer Cell Stemness and Dormancy in the Bone Microenvironment 113
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology 110
How the "seed" prepares the "soil": The bone/bone marrow pre-metastatic niche 106
Therapeutic compounds and compositions 100
A perspective on muscle phenotyping in musculoskeletal research 98
Reprint of: The Great Beauty of the osteoclast 95
Phenotype of the first mouse model of Cole Carpenter Syndrome. 92
A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders 92
A mutation in the ZNF687 gene that is responsible for the severe form of Paget's disease of bone causes severely altered bone remodeling and promotes hepatocellular carcinoma onset in a knock-in mouse model 91
Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background 88
The osteoclast in bone metastasis: Player and target 86
Osteopetrosis 86
Glycogen Storage Disease Type I and Bone: Clinical and Cellular Characterization 81
Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans 81
Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta 76
MC4R-dependent suppression of appetite by bone-derived lipocalin 2 74
Osteomimicry: Old concepts and new findings 68
Experimental therapies for osteopetrosis 68
Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation 68
High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench 63
Editorial: The bone/bone marrow microenvironment: A hub for immune regulation of the tumor cells fate 47
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 40
Priming-Dependent Modulation of Secretome in Placenta- and Adipose-Derived Mesenchymal Stromal/Stem Cells: Toward Cell-Free Immunoregenerative Therapies for Osteochondral and Degenerative Joint Diseases 5
Totale 4.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022153 0 0 30 10 7 9 6 16 21 9 9 36
2022/2023585 34 42 4 77 49 52 1 54 245 2 24 1
2023/2024229 17 16 16 7 20 60 3 1 6 11 6 66
2024/2025869 24 19 76 63 107 86 147 50 137 37 87 36
2025/20262.092 112 169 240 289 193 136 251 67 176 339 107 13
2026/2027125 45 61 19 0 0 0 0 0 0 0 0 0
Totale 4.605